Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have signed a consent form agreeing to take part in the study
- People aged between 18 and 60 years old
- People with a Body Mass Index (a measure of body weight relative to height) between 30 and 50
- People who can read and speak German well enough to understand patient instructions
For the "initially healthy" group within the trial, additional criteria apply:
- People with a blood pressure reading below 140/90 mmHg (considered a normal to mildly elevated range)
- People with blood sugar levels within a normal range — specifically, an HbA1c (a measure of average blood sugar over time) below 6.5% and a fasting blood glucose below 7.0 mmol/l
- People with LDL cholesterol (sometimes called "bad" cholesterol) below 5.0 mmol/l
- People who meet no more than 2 of the following: triglycerides (blood fats) above 1.7 mmol/l; HDL cholesterol (sometimes called "good" cholesterol) above 1.0 mmol/l for males or 1.3 mmol/l for females; fasting blood glucose at or above 5.6 mmol/l; blood pressure at or above 130/85 mmHg (confirm with trial site)
Who may not be able to join:
- People who are pregnant
- People taking medications, or who have health conditions, that would make it unsafe to have a small fat tissue sample (biopsy) taken
- People who have previously had, or are planning to have, weight-loss (bariatric) surgery
- People with medical conditions that would prevent them from completing the study's tests and examinations — for example, active heart or cardiovascular symptoms
- People who have an active cancer diagnosis, or who have been in remission for less than 2 years
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jörg Goldhahn, Prof., dTIP / ETH Zürich
Phone: 044 633 70 54
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rate of conversion
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.